Easywell Biomedicals, Inc.

TPEX:1799 Stock Report

Market Cap: NT$8.9b

Easywell Biomedicals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

James Aiping Lee

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership3.4%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Feb 12
What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

CEO

James Aiping Lee

no data

Tenure

Mr. James Aiping Lee, Ph D, is President of Easywell Biomedicals, Inc and serves as its Manager. He has extensive experience in both medical device and pharmaceutical industries.As the founder of Magnific...